Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Bifeprunox is a potent partial agonist of dopamine D2-like and 5-HT1A receptor (pEC50: 6.37 for hippocampus 5-HT1A; pKis: 7.19 and 8.83 for cortex 5-HT1A and striatum D2). It is an antipsychotic for the research of schizophrenia. |
Targets&IC50 | D2 receptor:8.83 (pKi), 5-HT1A receptor:6.37(pEC50), 5-HT1A receptor:7.19 (pKi) |
In vitro | Bifeprunox has a pKi of 8 at h5-HT1A receptors (Emax: 70%) [1]. |
In vivo | Bifeprunox (0.001-2.5 mg/kg) reduces marble burying in mice [2]. Bifeprunox (4-250 μg/kg) influences nicotine-seeking behavior in response to drug-associated stimuli in rats [3]. |
Molecular Weight | 385.46 |
Formula | C24H23N3O2 |
CAS No. | 350992-10-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bifeprunox 350992-10-8 Others inhibitor inhibit